{"name":"Innovative Cellular Therapeutics Co., Ltd.","slug":"innovative-cellular-therapeutics-co-ltd","ticker":"","exchange":"","domain":"","description":"Innovative Cellular Therapeutics Co., Ltd. is a biotechnology company focused on developing advanced cellular therapies, particularly in the field of CAR-T treatments. The company is currently advancing two drug candidates in Phase 1 clinical trials, targeting GUCY2C and CD19.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNTlVHbXpaNFRaTGxocDFLamFvZUFlMzMwMTBTM1djcFNaZkRzX2kwVnZ0Uk5pQzFsMDJOQWVBQXRJby1vQS12b092YndtNWxaZm5ROGhSTzk3V19EeDYwRzlUTkl5T1FuRTZTZlBiTWtpUlBBMkEzVXBtYWh2UVpFczFBWDA4QkFGcV9tRGg4MmQ0X0dwUENodm9EdjZtR2FraUo5ZE14WFJoZXlWb3pkaDNXUEdFODBPcXlKWWdZd0gwNEk1QnpoUV82NnJFLS10Q2EyaEtzbE01cGNSbGdJNg?oc=5","date":"2026-03-19","type":"pipeline","source":"Reuters","summary":"AstraZeneca to build cell therapy base, innovation centre in Shanghai - Reuters","headline":"AstraZeneca to build cell therapy base, innovation centre in Shanghai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1IWGt0aHk5LV9Ra2l3Z2FqQXB5am1RODZZaVIydHJvM2ZMX2R6bFJ4R0VGWjAwU25CdkYzY1VocnAwcGpTcnJTNXhYVU9zanB6Sk5pbE9NVk1OMURLeHM3VEdkWGRlcnPSAWxBVV95cUxOV05WRWNUVmU1Zy1QRzNXQlBwQjlUb2xieU91ekx1SmNQcXEwQ2dxVkxtaThLd21uUzFiaE1pWEVZVVJ3dUQ1RjNTelpyb3hyLVlHa3ZyT3Y5c0ZTQUM2MFRaTFNEYkp2X2E0N3c?oc=5","date":"2026-03-05","type":"pipeline","source":"BioInformant","summary":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformant","headline":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBscVlhT2h4SlJvZTB4dDFZa1lRYjdYQW1ZWVhUb3BDS1lzZHRVNmY1ZFJ5aEZGcFVqZEgwYmlDbnd0SWhyLXN0bzlCOUhJOUpPcGJjTDlMaGhFRkltdFJHTmo2aGtFX2VtRVRjSGgyRQ?oc=5","date":"2026-02-17","type":"pipeline","source":"VISTA.Today","summary":"Doylestown’s Aprea Therapeutics Names Industry Veteran as Chief Medical Advisor - VISTA.Today","headline":"Doylestown’s Aprea Therapeutics Names Industry Veteran as Chief Medical Advisor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-22","type":"pipeline","source":"simplywall.st","summary":"Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) one-year returns climbed after last week's 13% gain, institutional investors must be happy - simplywall.st","headline":"Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) one-year returns climbed after last week's 13% gain, institutional investors mu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxORWRhT2R4VnRpazBTNE1fMjU5Y3hrZ09JcUZCMnFIYVRUa1l1R2xDWmFDbnhqWEJKZmNVeWZDZTBUcS05Y1NKNFotTzAxMDFJTVpQLWt5ZkRicm5aaG9Bd1BZQVp1VUhGTGxhQWtoTE43R1c2eDN6UGFZdHVtNWdRUnNVTQ?oc=5","date":"2025-11-11","type":"deal","source":"Pharmaceutical Technology","summary":"Lyell acquires worldwide rights from ICT to CAR T-cell therapy - Pharmaceutical Technology","headline":"Lyell acquires worldwide rights from ICT to CAR T-cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPaGJSV1hnbFN4cE5OcWNDTWNfMWVCU1picWs0Z2kweFVmTzYzZWJNcXRTeVpBMUNQNXF4d0tDSmxqdU1VV2RQcGxjWFhJZlVfTzQ5NjgwSG91VnhiZWt1MENIVXJIa3AybXJ3ZmJMNFFQV3RFNm9nRmtpczlTbXNnUGVBaUJiQVY1Z0JNQ2ZQclJUTlF0NGdhLWU5UGxmakNxX1RjSnlLQjdTaXUw?oc=5","date":"2025-11-10","type":"trial","source":"Fierce Biotech","summary":"Lyell hands over $70M-plus in cash, equity for 'impressive' phase 1-stage colorectal cancer CAR-T - Fierce Biotech","headline":"Lyell hands over $70M-plus in cash, equity for 'impressive' phase 1-stage colorectal cancer CAR-T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxORExra0pqMmhTQ25YV2ZnYkl4OG05d2x4NXg0eHB4ZUozd2ptMWZvQWFzaGlBN1dIblZjeUZmckpJZGpVTGtBby1oOWtMZm0tNUMteEl6RjlUemtka01oMVhvTlZFeDY1RDc3YVkyRDlIRzE2Qkt1MmNISllONzVlWU1HV2xYQmx2eVc2MUZfX3N2dVhGRHhzMUV1UlRPLWw5b2ROTDA1bTQydzQ?oc=5","date":"2025-11-04","type":"pipeline","source":"Deloitte","summary":"Charting the next wave of growth and innovation in advanced therapies - Deloitte","headline":"Charting the next wave of growth and innovation in advanced therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPQm5Bb2ZDM2VWb0hRY3VGOWFSekdBV25HVUhFVk83YzBsZlQ2VHl4T1NKS1RpcjR4T2dDUl9rOXBwaTZ6dkZJSWkzUmZTZjZNVEdwRDZOWlBLU1BQdmJzSEVkb2V4emFVTGwyUFIxOEV2emwyQUN5SlBSQ01HRVBReTRwdzR1dm5oZUZQQTNFQ3dBcGJfX1ZpV2hZYlpkdFhWZG5MSm5jV1RhcS1KVUNXRExXYXQ1SkdWX2gzbi0wMDZEZTA?oc=5","date":"2025-07-13","type":"pipeline","source":"Bloomberg.com","summary":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline - Bloomberg.com","headline":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNZThaVC01a01fMEVoQnloNVRDYTlmdm01M2ZIRFQ3Q2FzbUxTblBIbHRIY1lXVzBjazVJN3BaMHFLcDVwMzRvWVBiYlNWMUVzSmJQWjlLOHU3d1hrUFh1clRFMkdTakoxSzdBQ3FOdlMtSjRocEJjNGx4a2I3U3ZYaEVlMy02TG9icHdoOEdCTTZFUXNIOWxwNzd4ajhDaUQtSzBiU1EtdlRWaUxFaHk0bEo1OFQwWU42NFE3YTQwbzl0XzY4TW5PbElsZWlmOTNy?oc=5","date":"2025-05-26","type":"trial","source":"BioPharma APAC","summary":"UniXell Biotech Initiates China’s First iPSC-Based Cell Therapy Trial for Parkinson’s Disease - BioPharma APAC","headline":"UniXell Biotech Initiates China’s First iPSC-Based Cell Therapy Trial for Parkinson’s Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxPSlFhcVdwaFlONm5LenM3akJpY2hmc04zT3hMeWFVMm50ZTBMTWNZNlFWRFBUOUdJZ010blhQNkpKR1gzd2NwN0lDOXFRQlFQVmZZSW82aDRiYU94a3VaZDkxWWsxTWJGUEJlNnJWa1pGV2FEZkFLX3QyVWJJSDQ2ajgxZnVQY25wZnloZ3RBOVR4RGhSZ1REYjhHWGhzeTlmVjFmbEQ5b1ZSTktKQzltVDM0bHdBNm1DSEM2S1VSbEl0a0QybjUzZE5laFF2YTFqSkZNYlVrdXBKQm9lVjlZTTZiSDMwa3YzMUgwaHAxeV82LVNKZTFoZUI5ZG1NbThqUlE5bEFBUWJ6Rm5XcVV5Q2VWNl9NREdCN2lycUhOU2otUEh6NDBmSERtS3VPaENoMnI3M0tKRmxmTjg?oc=5","date":"2025-05-13","type":"trial","source":"GlobeNewswire","summary":"Metastatic Colorectal Cancer Clinical Trial Pipeline - GlobeNewswire","headline":"Metastatic Colorectal Cancer Clinical Trial Pipeline","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxOOEloNzBMUVo2VDlxYlpXM2NsZWh0Zmgyb0dZc2dWaXJNUm9adUtqNmdKaWVIWGZnbFJrdWE3bHhZeFlMYkZfc1lpb0N3TXVRQXExTUJaQUZFWFdOTlJOQjhsYkpBM2piWEhJazBwRlpKaUs2YzN0LWFyLW1OUFFSREpRM1IzbklTVkU0Y2RSUHB6TTdnNG0zUGZMVHNnWHhhVlZMRXdwNklETXVwY0tSQ2J3am82VmpRQ2dRX2d6WHh0cGg0TGR4ZEVTb1JGYXNKX2I4S0xBcDFsSWRla1JmaXEzdHdGTVlPcXVXSXJWekRLdUNzQk1VS1YzMVVQVjE2eFZLQjB6Y2JhWFZTbWZXN2l5OFRlOEYxZ3o2ZHFHMkJuMUdZM0ltX3NJRTJSNWVZTWUybThENGFlSWh4ZWc?oc=5","date":"2025-04-23","type":"pipeline","source":"PR Newswire","summary":"Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakthrough Therapies Gain Traction | DelveInsight - PR Newswire","headline":"Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakt","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}